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Cell junctions (or intercellular bridge) are structures that exist within the tissue of
some multicellular organisms. Cell junctions consist of multiprotein complexes
that provide contact between neighboring cells or between a cell and the
extracellular matrix. They also build up the paracellular barrier of epithelia and
control the paracellular transport. Cell junctions are especially abundant in
epithelial tissues.Cell junctions are especially important in enabling
communication between neighboring cells via specialized proteins called
communicating junctions. Cell junctions are also important in reducing stress
placed upon cells.
Epithelial cells are in close contact with each other by tight junctions, adherens
junctions and gap junctions that connect these cells. In the epithelial cell to
mesenchymal cell transformation process, the cell and cell connection will
gradually dissociate. With the close connection and the dissociation of the
attachment structure of the dissociation, epithelial cell morphology and phenotype
have changed, the cells lost close growth status, showing sparse, loose growth,
cells showed spindle shape. There are more studies on tight junctions, and
relatively few for adherent connections.
In this paper, the protein of p120 in NMUMG of mouse mammary epithelial cells
was knocked out specifically by using CRISPR / Cas9 technique, and p120 stable
knockout cell line was constructed. It was found that NMUMG cells lost close
growth after knockout of p120, and showed a loose growth state, and the cell
morphology changed. And then by replenishing the wild type p120, NMUMG was
found to be able to return to normal cell growth. This proves that p120 is essential
for NMUMG to maintain normal cell morphology. Through immunofluorescence
experiments, it can be seen that E-cadherin is dissociated from the cell













adhesion, which means that the disappearance of adhesion between NMUMG
cells Indicating that p120 can stabilize E-cadherin, promote the formation of
adhesion between epithelial cells. And for p120 is how to stabilize E-cadherin to
control the adhesion of the connection, pending further study.
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